Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4ICQ2
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0003924 | GTPase activity | 7 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0005525 | GTP binding | 5 | 11 |
GO:0016462 | pyrophosphatase activity | 5 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 11 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 11 |
GO:0017076 | purine nucleotide binding | 4 | 11 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 11 |
GO:0019001 | guanyl nucleotide binding | 5 | 11 |
GO:0032553 | ribonucleotide binding | 3 | 11 |
GO:0032555 | purine ribonucleotide binding | 4 | 11 |
GO:0032561 | guanyl ribonucleotide binding | 5 | 11 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 11 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043168 | anion binding | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0097367 | carbohydrate derivative binding | 2 | 11 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 272 | 274 | PF00082 | 0.453 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.414 |
CLV_PCSK_PC1ET2_1 | 272 | 274 | PF00082 | 0.453 |
CLV_PCSK_PC1ET2_1 | 96 | 98 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 202 | 206 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.512 |
CLV_PCSK_SKI1_1 | 273 | 277 | PF00082 | 0.516 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.368 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.322 |
DEG_APCC_DBOX_1 | 39 | 47 | PF00400 | 0.453 |
DOC_CYCLIN_RxL_1 | 23 | 33 | PF00134 | 0.518 |
DOC_CYCLIN_RxL_1 | 37 | 47 | PF00134 | 0.381 |
DOC_MAPK_gen_1 | 108 | 117 | PF00069 | 0.414 |
DOC_MAPK_gen_1 | 125 | 133 | PF00069 | 0.406 |
DOC_MAPK_gen_1 | 200 | 207 | PF00069 | 0.347 |
DOC_MAPK_gen_1 | 93 | 101 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 125 | 133 | PF00069 | 0.374 |
DOC_MAPK_MEF2A_6 | 200 | 207 | PF00069 | 0.319 |
DOC_USP7_MATH_1 | 275 | 279 | PF00917 | 0.528 |
DOC_USP7_MATH_1 | 73 | 77 | PF00917 | 0.628 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.156 |
DOC_USP7_UBL2_3 | 272 | 276 | PF12436 | 0.541 |
DOC_WW_Pin1_4 | 125 | 130 | PF00397 | 0.340 |
LIG_14-3-3_CanoR_1 | 108 | 118 | PF00244 | 0.369 |
LIG_14-3-3_CanoR_1 | 97 | 102 | PF00244 | 0.412 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.508 |
LIG_EH_1 | 33 | 37 | PF12763 | 0.459 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.273 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.373 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.464 |
LIG_FHA_1 | 241 | 247 | PF00498 | 0.363 |
LIG_FHA_1 | 96 | 102 | PF00498 | 0.290 |
LIG_GBD_Chelix_1 | 252 | 260 | PF00786 | 0.412 |
LIG_LIR_Gen_1 | 264 | 275 | PF02991 | 0.394 |
LIG_LIR_Gen_1 | 33 | 43 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 166 | 171 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 264 | 270 | PF02991 | 0.376 |
LIG_LIR_Nem_3 | 33 | 39 | PF02991 | 0.439 |
LIG_NRBOX | 38 | 44 | PF00104 | 0.522 |
LIG_Pex14_1 | 160 | 164 | PF04695 | 0.300 |
LIG_Pex14_2 | 156 | 160 | PF04695 | 0.300 |
LIG_SH2_CRK | 267 | 271 | PF00017 | 0.492 |
LIG_SH2_STAP1 | 267 | 271 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.452 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.316 |
LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.454 |
LIG_SH3_3 | 29 | 35 | PF00018 | 0.471 |
LIG_SH3_3 | 52 | 58 | PF00018 | 0.562 |
LIG_SH3_5 | 139 | 143 | PF00018 | 0.409 |
LIG_SUMO_SIM_par_1 | 97 | 103 | PF11976 | 0.402 |
LIG_UBA3_1 | 19 | 26 | PF00899 | 0.483 |
LIG_UBA3_1 | 204 | 211 | PF00899 | 0.343 |
LIG_WRC_WIRS_1 | 101 | 106 | PF05994 | 0.296 |
MOD_CK1_1 | 176 | 182 | PF00069 | 0.403 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.691 |
MOD_CK2_1 | 113 | 119 | PF00069 | 0.444 |
MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.336 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.300 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.440 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.610 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.432 |
MOD_GSK3_1 | 109 | 116 | PF00069 | 0.312 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.599 |
MOD_N-GLC_2 | 144 | 146 | PF02516 | 0.412 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.428 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.431 |
MOD_NEK2_1 | 231 | 236 | PF00069 | 0.231 |
MOD_PIKK_1 | 56 | 62 | PF00454 | 0.610 |
MOD_Plk_1 | 4 | 10 | PF00069 | 0.529 |
MOD_Plk_4 | 113 | 119 | PF00069 | 0.355 |
MOD_ProDKin_1 | 125 | 131 | PF00069 | 0.340 |
MOD_SUMO_for_1 | 281 | 284 | PF00179 | 0.486 |
MOD_SUMO_for_1 | 92 | 95 | PF00179 | 0.347 |
MOD_SUMO_rev_2 | 119 | 128 | PF00179 | 0.444 |
TRG_DiLeu_BaLyEn_6 | 200 | 205 | PF01217 | 0.343 |
TRG_ENDOCYTIC_2 | 267 | 270 | PF00928 | 0.364 |
TRG_Pf-PMV_PEXEL_1 | 188 | 192 | PF00026 | 0.418 |
TRG_Pf-PMV_PEXEL_1 | 211 | 215 | PF00026 | 0.391 |
TRG_Pf-PMV_PEXEL_1 | 40 | 45 | PF00026 | 0.542 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P886 | Leptomonas seymouri | 68% | 99% |
A0A0S4JWF1 | Bodo saltans | 42% | 100% |
A0A1X0P850 | Trypanosomatidae | 51% | 100% |
A0A3S7XAE0 | Leishmania donovani | 100% | 100% |
A0A422NK26 | Trypanosoma rangeli | 52% | 94% |
A4HNU2 | Leishmania braziliensis | 81% | 95% |
D0A2Q7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
E9ASK2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q3SXY8 | Homo sapiens | 35% | 70% |
Q4Q1Z4 | Leishmania major | 97% | 100% |
Q640N2 | Mus musculus | 37% | 70% |